A bill introduced by Representatives Bobby Rush (D-IL) and Henry Waxman (D-CA) on 9 February would end so-called "pay-for-delay" settlements used by pharmaceutical companies to delay competition from generic competitors. The bill, Protecting Consumer Access to Generic Drugs Act of 2012 (H.R. 3995) , declares it "unlawful for any person to directly or indirectly be a party to any agreement resolving or settling a patent infringement claim in which (1) an [Abbreviated ...